Home
Companies
Catalysts
Deep Dives
MOG antibody disease
MOGAD · Neurology · 1 drugs · 1 indications
Competitive Landscape (1 drugs)
Drug
Company
Mechanism
Modality
Route
Stage
Rystiggo
UCB
FcRn Inhibitor
Antibody
SC
APPROVED
Indications (1)
MOG antibody disease
Rystiggo
PHASE3
Upcoming Catalysts
Rystiggo - MOG Antibody Disease - Ph3 - Headline Results
CLINICAL
UCB
H2 2026
Data from Supabase · Updated 2026-03-24